Ascentage Pharma Group International (ASPHF) Stock Chart & Stock Price History $5.83 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort Interest Ascentage Pharma Group International Stock Price Performance 5 Day PerformanceN/A1 Month Performance0.00%3 Month PerformanceN/A6 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A Receive ASPHF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. Email Address ASPHF Stock Chart for Saturday, February, 22, 2025 ASPHF Chart by TradingView Ascentage Pharma Group International Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/13/2025$5.83$5.83$5.83$5.831 shs$0.0001/30/2025$5.83$5.83$5.83$5.8340 shs$0.0001/29/2025$5.83$5.83$5.83$5.8350 shs$0.0001/28/2025$5.83$5.83$5.83$5.83320 shs$0.0001/23/2025$5.83$5.83$5.83$5.83400 shs$0.0001/22/2025$5.42$5.83+7.47%$5.83$5.83400 shs$0.0001/21/2025$6.45$5.42-15.97%$5.42$5.42166 shs$0.00 Related Companies ATNFW Stock Price Chart TRSBF Stock Price Chart SXTPW Stock Price Chart ABCZF Stock Price Chart AGTX Stock Price Chart AGNPF Stock Price Chart AKBLF Stock Price Chart DRTSW Stock Price Chart WENAW Stock Price Chart APLMW Stock Price Chart Receive ASPHF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ASPHF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
